Current research studies point out that AD and T2DM might share some underlying mechanisms and putative biochemical pathways, i.e., the desensitization of insulin signaling, most likely driven by chronic inflammation, and mitochondrial dysfunction, as a consequence of increased oxidative stress or vasculopathy [10,11]. Here, INS is linked to Alzheimer disease.